Atea Pharmaceuticals Inc Earnings

The next earnings date for Atea Pharmaceuticals Inc has not yet been scheduled.

Analyst Estimates of Atea Pharmaceuticals Inc Earnings

No Results.

Report Date	Estimated Earnings Per Share
No Results.

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Atea Pharmaceuticals Inc Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
11/06/2025	---	$0	100.00%
08/07/2025	---	$-0.44	-7.32%
08/06/2025	---	$0	100.00%
02/26/2025	After Market	$-0.40	-38.12%
11/07/2024	After Market	$-0.37	24.49%
08/07/2024	After Market	$-0.48	36.84%
05/14/2024	After Market	$-0.75	-22.95%
02/28/2024	After Market	$-0.47	6.00%
11/08/2023	After Market	$-0.40	16.67%
08/08/2023	After Market	$-0.34	27.66%
05/08/2023	After Market	$-0.43	10.42%
02/28/2023	After Market	$-0.41	8.89%
11/07/2022	After Market	$-0.10	77.27%
08/08/2022	After Market	$-0.38	26.92%
05/10/2022	Before Market	$-0.51	12.07%
02/28/2022	After Market	$1.34	688.24%
11/11/2021	After Market	$-0.34	-580.00%
08/12/2021	After Market	$0.02	100.00%
05/13/2021	After Market	$0.34	780.00%
03/30/2021	After Market	$0.96	500.00%
12/10/2020	After Market	$-1.74	-65.71%
09/02/2020	---	$-0.16	---
06/19/2020	---	$-0.03	---

More About Atea Pharmaceuticals Inc

Website

https://ateapharma.com

Country

USA

Full Time Employees

Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes oral antiviral therapeutics for patients with serious viral infections. Its lead product candidate is the regimen of bemnifosbuvir, a nucleotide NS5B inhibitor, and ruzasvir, an NS5A inhibitor, which is in Phase 3 clinical trial for the treatment of hepatitis C virus (HCV). It has a license agreement with MSD International GmbH for the development, manufacture, and commercialization of ruzasvir. Atea Pharmaceuticals, Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.

“Atea Pharmaceuticals Inc Earnings” Can Refer to the Atea Pharmaceuticals Inc Earnings Date

Some people say “Atea Pharmaceuticals Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Atea Pharmaceuticals Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Atea Pharmaceuticals Inc Stock on the Earnings Date

If you own Atea Pharmaceuticals Inc stock (AVIR) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Atea Pharmaceuticals Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Atea Pharmaceuticals Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Atea Pharmaceuticals Inc Earnings

You can contact us any time if you would like to ask questions about Atea Pharmaceuticals Inc earnings or anything else related to the stock market.